Literature DB >> 18594466

Anaplastic large cell lymphoma associated with a breast implant capsule: a case report and review of the literature.

Anna K Wong1, Jean Lopategui, Sharon Clancy, David Kulber, Shikha Bose.   

Abstract

Primary lymphomas of the breast are rare and predominately of B-cell phenotype. Anaplastic large cell lymphoma is a T-cell lymphoma that accounts for only 3% of all non-Hodgkin lymphomas. We present a rare case of primary anaplastic large cell lymphoma of the breast in association with a silicone breast implant capsule in a healthy 40-year-old woman. The patient had bilateral breast implants placed at 21 years of age and presented with painful bilateral breast contractures and associated breast asymmetry. Histology, immunohistochemistry, and T-cell gene rearrangement studies were supportive of a CD 30-positive ALK-1 negative anaplastic large cell lymphoma. This case represents the 14th reported case of primary breast lymphoma in association with breast prosthesis. Of interest is that 11 of these cases were T-cell lymphomas with 8 specifically of the CD30-positive anaplastic large cell lymphoma type. This rare case highlights the importance of histologic examination of breast capsule specimens.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18594466     DOI: 10.1097/PAS.0b013e318162bcc1

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  17 in total

Review 1.  Breast Implant-Associated Anaplastic Large-Cell Lymphoma: Current Understanding and Recommendations for Management.

Authors:  Tessa L St Cyr; Barbara A Pockaj; Donald W Northfelt; Fiona E Craig; Mark W Clemens; Raman C Mahabir
Journal:  Plast Surg (Oakv)       Date:  2020-05-21       Impact factor: 0.947

2.  Breast implant-associated, ALK-negative, T-cell, anaplastic, large-cell lymphoma: establishment and characterization of a model cell line (TLBR-1) for this newly emerging clinical entity.

Authors:  Melissa G Lechner; Stephen Lade; Daniel J Liebertz; H Miles Prince; Garry S Brody; Howard R Webster; Alan L Epstein
Journal:  Cancer       Date:  2010-11-08       Impact factor: 6.860

Review 3.  Breast implant-associated anaplastic large cell lymphoma: a systematic review of the literature and mini-meta analysis.

Authors:  Philip A Thompson; H Miles Prince
Journal:  Curr Hematol Malig Rep       Date:  2013-09       Impact factor: 3.952

Review 4.  CD30+ neoplasms of the skin.

Authors:  Madeleine Duvic
Journal:  Curr Hematol Malig Rep       Date:  2011-12       Impact factor: 3.952

5.  Anaplastic large cell lymphoma associated with breast implants.

Authors:  Shalini Ravi-Kumar; Omid Sanaei; Mohammad Vasef; Ian Rabinowitz; Mohammad Houman Fekrazad
Journal:  World J Plast Surg       Date:  2012-01

6.  Primary anaplastic large-cell lymphoma associated with breast implants.

Authors:  Leslie Popplewell; Sandra H Thomas; Qin Huang; Karen L Chang; Stephen J Forman
Journal:  Leuk Lymphoma       Date:  2011-06-24

Review 7.  Breast implant-associated ALCL: a unique entity in the spectrum of CD30+ lymphoproliferative disorders.

Authors:  Sara K Story; Michael K Schowalter; Larisa J Geskin
Journal:  Oncologist       Date:  2013-02-21

8.  Rare lymphoid malignancies of the breast: a report of two cases illustrating potential diagnostic pitfalls.

Authors:  Evan A Farkash; Judith A Ferry; Nancy Lee Harris; Ephraim P Hochberg; Ronald W Takvorian; Dan S Zuckerman; Aliyah R Sohani
Journal:  J Hematop       Date:  2009-08-20       Impact factor: 0.196

9.  Breast implant-associated ALK-negative anaplastic large cell lymphoma: a case report and discussion of possible pathogenesis.

Authors:  Eva V George; John Pharm; Courtney Houston; Semar Al-Quran; Grey Brian; Huijia Dong; Wang Hai; Westley Reeves; Li-Jun Yang
Journal:  Int J Clin Exp Pathol       Date:  2013-07-15

10.  Silicone implant and primary breast ALK1-negative anaplastic large cell lymphoma, fact or fiction?

Authors:  Shiyong Li; Andrew K Lee
Journal:  Int J Clin Exp Pathol       Date:  2009-10-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.